Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Agents - Akihiro Hirakawa, Hiroyuki Sato, Takashi Daimon, Shigeyuki Matsui (Springer, 2018)